中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2014年
6期
12-13
,共2页
肠梗阻%胃肠肿瘤%奥曲肽
腸梗阻%胃腸腫瘤%奧麯肽
장경조%위장종류%오곡태
Intestinal obstruction%Gastrointestinal tumor%Octreotide
目的:探讨胃肠肿瘤术后肠梗阻的临床特点及保守治疗方法。方法回顾性分析2005年1月至2012年1月我科收治的69例胃肠肿瘤术后肠梗阻患者的原发部位、梗阻类型、原发肿瘤分化、分期与良、恶性梗阻的关系,以及常规治疗与加用奥曲肽保守治疗疗效比较。结果69例肠梗阻中,23例恶性肠梗阻,46例良性肠梗阻,原发肿瘤分化较差、分期较晚者更多发生恶性肠梗阻(P<0.01);恶性肠梗阻多为不全性肠梗阻,而完全性肠梗阻多发生在良性肠梗阻患者(P<0.05);肠梗阻保守治疗加用奥曲肽疗效高于常规治疗组(P<0.05)。结论肠梗阻类型、原发肿瘤分化、分期可作为判断梗阻良恶性病因的因素之一。对肠梗阻的保守治疗,在既往常规治疗的基础上加用奥曲肽是一个即安全又有效的方法。
目的:探討胃腸腫瘤術後腸梗阻的臨床特點及保守治療方法。方法迴顧性分析2005年1月至2012年1月我科收治的69例胃腸腫瘤術後腸梗阻患者的原髮部位、梗阻類型、原髮腫瘤分化、分期與良、噁性梗阻的關繫,以及常規治療與加用奧麯肽保守治療療效比較。結果69例腸梗阻中,23例噁性腸梗阻,46例良性腸梗阻,原髮腫瘤分化較差、分期較晚者更多髮生噁性腸梗阻(P<0.01);噁性腸梗阻多為不全性腸梗阻,而完全性腸梗阻多髮生在良性腸梗阻患者(P<0.05);腸梗阻保守治療加用奧麯肽療效高于常規治療組(P<0.05)。結論腸梗阻類型、原髮腫瘤分化、分期可作為判斷梗阻良噁性病因的因素之一。對腸梗阻的保守治療,在既往常規治療的基礎上加用奧麯肽是一箇即安全又有效的方法。
목적:탐토위장종류술후장경조적림상특점급보수치료방법。방법회고성분석2005년1월지2012년1월아과수치적69례위장종류술후장경조환자적원발부위、경조류형、원발종류분화、분기여량、악성경조적관계,이급상규치료여가용오곡태보수치료료효비교。결과69례장경조중,23례악성장경조,46례량성장경조,원발종류분화교차、분기교만자경다발생악성장경조(P<0.01);악성장경조다위불전성장경조,이완전성장경조다발생재량성장경조환자(P<0.05);장경조보수치료가용오곡태료효고우상규치료조(P<0.05)。결론장경조류형、원발종류분화、분기가작위판단경조량악성병인적인소지일。대장경조적보수치료,재기왕상규치료적기출상가용오곡태시일개즉안전우유효적방법。
Objective To investigate the clinical characteristics of gastric cancer postoperative Intestinal obstruction and conservative treatment method. Methods a retrospective analysis from January 2005 to January 2012 our department treated 69 cases of gastric cancer postoperative Intestinal obstruction patients of primary site, the types of obstruction, primary tumor differentiation, relations with benign and malignant obstruction in stages, and regular treatment and combined with the octreotide compared curative effect of conservative treatment. Results In 69 cases of intestinal obstruction, 23 cases of malignant obstruction, 46 cases of benign intestinal obstruction, poor primary tumor differentiation, staging occurs late more malignant obstruction(P<0.01);Malignancy intestinal obstruction for incomplete Intestinal obstruction, and more complete intestinal obstruction occurred in patients with benign intestinal obstruction(P<0.05);Intestinal obstruction treated conservatively and with Mr Song peptide curative effect than conventional treatment group(P<0.05). Conclusion Intestinal obstruction type, primary tumor differentiation, staging can be as one of judge obstruction factors of benign and malignant causes. Conservative treatment of intestinal obstruction, in the past on the basis of conventional treatment combined with Mr Qu peptide is a safe and effective method.